Double-stranded RNA induces melanocyte death via activation of Toll-like receptor 3

Experimental Dermatology

Volumn 20, Issue 2, 2011, Pages 134-139

  Yu, Ning ^a   Zhang, Shujie ^b   Sun, Tao ^a   Kang, Kefei ^a   Guan, Ming ^a   Xiang, Leihong ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; DsRNA; Melanocyte; Poly(I:C); Toll like receptor 3

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; BETA INTERFERON; DOUBLE STRANDED RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 1; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; NEUTRALIZING ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 3; VIRUS RNA;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INTERFERON PRODUCTION; INTRACELLULAR SIGNALING; MELANOCYTE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA ISOLATION; WESTERN BLOTTING;

APOPTOSIS; CELLS, CULTURED; HUMANS; INTERFERON INDUCERS; INTERFERON-BETA; MALE; MELANOCYTES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLY I-C; RNA, DOUBLE-STRANDED; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3;

EID: 78751685213     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2010.01208.x     Document Type: Article

References (51)

1. al Badri AM, Foulis AK, Todd PM et al. J Pathol 1993: 169: 203-206.
2. Lu Y, Zhu WY, Tan C et al. Pigment Cell Res 2002: 15: 454-460.
3. Yohn JJ, Critelli M, Lyons MB et al. J Invest Dermatol 1990: 95: 233-237.
4. Smit N, Le Poole I, van den Wijngaard R et al. Arch Dermatol Res 1993: 285: 356-265.
5. Swope VB, Sauder DN, McKenzie RC et al. J Invest Dermatol 1994: 102: 749-753.
6. Krüger-Krasagakes S, Krasagakis K, Garbe C et al. Recent Results Cancer Res 1995: 139: 155-168.
7. Rezaei N, Gavalas NG, Weetman AP et al. J Eur Acad Dermatol Venereol 2007: 21: 865-876.
8. Damico FM, Bezerra FT, Silva GC et al. Arq Bras Oftalmol 2009: 72: 413-420.
9. Harson R, Grose C. J Virol 1995: 69: 4994-5010.
10. Grimes PE, Sevall JS, Vojdani A. J Am Acad Dermatol 1996: 35: 21-26.
11. Tsuboi H, Yonemoto K, Katsuoka K. J Dermatol 2006: 33: 577-578.
12. Soylu S, Gül U, Gönül M et al. Am J Clin Dermatol 2009: 10: 336-338.
13. Cho M, Cohen PR, Duvic M. South Med J 1995: 88: 489-491.
14. Seyedalinaghi SA, Karami N, Hajiabdolbaghi M et al. J Eur Acad Dermatol Venereol 2009: 23: 840-841.
15. Bassili SS, Peyman GA, Gebhardt BM et al. Retina 1996: 16: 160-161.
16. Erf GF, Bersi TK, Wang X et al. Pigment Cell Res 2001: 14: 40-46.
17. Desailloud R, Hober D. Virol J 2009: 6: 5.
18. Jun HS, Yoon JW. Diabetologia 2001: 44: 271-285.
19. Akira S, Takeda K. Nat Rev Immunol 2004: 4: 499-511.
20. Olaru F, Jensen LE. Exp Dermatol 2010: 19: 314-316.
21. Ahn JH, Park TJ, Jin SH et al. Exp Dermatol 2008: 17: 412-417.
22. Kang HY, Park TJ, Jin SH. J Invest Dermatol 2009: 129: 243-246.
23. Yu N, Zhang S, Zuo F et al. J Dermatol Sci 2009: 56: 113-120.
24. Alexopoulou L, Holt AC, Medzhitov R et al. Nature 2001: 413: 732-738.
25. Dogusan Z, García M, Flamez D et al. Diabetes 2008: 57: 1236-1245.
26. Beuret L, Flori E, Denoyelle C et al. J Biol Chem 2007: 282: 14140-14147.
27. Lee H, Park C, Cho IH et al. Glia 2007: 55: 712-722.
28. Watanabe A, Hashmi A, Gomes DA et al. Hepatology 2007: 46: 1509-1518.
29. Marín YE, Seiberg M, Lin CB. Exp Dermatol 2009: 18: 611-618.
30. Chiron D, Pellat-Deceunynck C, Amiot M et al. J Immunol 2009: 182: 4471-4478.
31. Jiang Q, Wei H, Tian Z. BMC Cancer 2008: 8: 12-20.
32. Schallreuter KU, Bahadoran P, Picardo M et al. Exp Dermatol 2008: 17: 139-140.
33. Salaun B, Coste I, Rissoan MC et al. J Immunol 2006: 176: 4894-4901.
34. Yoneda K, Sugimoto K, Shiraki K et al. Int J Oncol 2008: 33: 929-936.
35. Rasschaert J, Ladrière L, Urbain M et al. J Biol Chem 2005: 280: 33984-33991.
36. Matsumoto M, Seya T. Adv Drug Deliv Rev 2008: 60: 805-812.
37. Kovalenko A, Kim JC, Kang TB et al. J Exp Med 2009: 206: 2161-2177.
38. Cardoso SM, Oliveira CR. Free Radic Res 2003: 37: 967-973.
39. Vousden KH. Aging (Albany NY) 2009: 1: 275-277.
40. Dutta J, Fan Y, Gupta N et al. Oncogene 2006: 25: 6800-6816.
41. Amiri KI, Richmond A. Cancer Metastasis Rev 2005: 24: 301-313.
42. Harris J, Bines S, Das Gupta T. Med Pediatr Oncol 1994: 22: 103-106.
43. Bernstein D, Reddy KR, Jeffers L et al. Am J Gastroenterol 1995: 90: 1176-1177.
44. Simsek H, Savas C, Akkiz H et al. Dermatology 1996: 193: 65-66.
45. Krasagakis K, Garbe C, Krüger S et al. J Invest Dermatol 1991: 97: 364-372.
46. Creagh EM, Conroy H, Martin SJ. Immunol Rev 2003: 193: 10-21.
47. Kingo K, Aunin E, Karelson M et al. J Dermatol Sci 2008: 52: 39-46.
48. Song X, Xu A, Pan W et al. Int J Mol Med 2008: 22: 9-16.
49. Weston CR, Balmanno K, Chalmers C et al. Oncogene 2003: 22: 1281-1293.
50. Mebratu Y, Tesfaigzi Y. Cell Cycle 2009: 8: 1168-1175.
51. Lai Y, Di Nardo A, Nakatsuji T et al. Nat Med 2009: 15: 1377-1382.